Erratum

In the Review by Jacob Thomas and Mark R Hutchinson, ‘Exploring neuroinflammation as a potential avenue to improve the clinical efficacy of opioids’, published in the November 2012 issue of Expert Review of Neurotherapeutics (Expert Rev. Neurother. 12[11], 1311–1324 [2012]), on page 1317, the following figure appeared as:

Figure 2. Opioid-induced central immune signaling.

CCK: Cholecystokinin.

The corrected figure is overleaf.

The figure should have read:

Figure 2. Opioid-induced central immune signaling.

CCK: Cholecystokinin.

The editors of Expert Review of Neurotherapeutics would like to sincerely apologize for any inconvenience or confusion this may have caused our readers.